May 9, 2016
Der lab finds promising drug to fight pancreatic cancer
In the lab of Channing Der, PhD, researchers believe they have found a promising strategy to target a type of pancreatic cancer that is notoriously resistant to treatment—pancreatic cancer that has a mutation in a gene called KRAS.